SHH and neoplasm: High-throughput single-cell transcriptomic analysis of Sonic Hedgehog (SHH)-driven medulloblastomas before and after initiation of SHH inhibitor may determine whether intra-tumor heterogeneity contributes to the process of therapeutic failure.